LobbyingVifor Pharma lobbying by quarter
Vifor Pharma's latest lobbying report covers Q3 2025, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues.
Vifor Pharma
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $0 | 1 |
| Q1 2023 | $10K | 1 |
| Q2 2023 | $20K | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $20K | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$50K · 8 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Sidley Austin | $50K | 12 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| PATRICIA LOUISE DELOATCHE | Health Policy Director, Sen. Orrin Hatch; Chief of Staff, Legislative Director, Legislative Assistant, Rep. Mike Bilirakis | Q3 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/10/17for Q3 2025 | Sidley Austin | Under $5,000 |
| 25/07/18for Q2 2025 | Sidley Austin | Under $5,000 |
| 25/04/18for Q1 2025 | Sidley Austin | $20K |
| 25/01/17for Q4 2024 | Sidley Austin | Under $5,000 |
| 24/10/18for Q3 2024 | Sidley Austin | Under $5,000 |
| 24/07/19for Q2 2024 | Sidley Austin | Under $5,000 |
| 24/04/19for Q1 2024 | Sidley Austin | Under $5,000 |
| 24/01/19for Q4 2023 | Sidley Austin | Under $5,000 |
| 23/10/19for Q3 2023 | Sidley Austin | Under $5,000 |
| 23/07/19for Q2 2023 | Sidley Austin | $20K |
| 23/04/19for Q1 2023 | Sidley Austin | $10K |
| 23/01/19for Q4 2022 | Sidley Austin | Under $5,000 |